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Studies on the transcobalamin receptor in hog kidney. The binding of 
the cobalamin-trans cobalamin complex by its solubilized receptor from 
hog kidney membrane was studied. The receptor bound the complex in 
a system containing bivalent cations, and the affinity was dependent on 
the NaCI concentration but not on temperature. The binding of coba-
lamin-transcobalamin to the receptor had an association constant of 
approximately 4.6 x 109 liter/mol and it was saturable and highly 
specific as competition by other proteins was not observed. The 
receptor had higher affinity for the cobalamin-transcobalamin complex 
(holo-TC) than for transcobalamin (apo-TC). Basic amino compounds 
known to interfere with tubular reabsorption of proteins did not inhibit 
the binding. Studies on subcellular fractions supported the view that the 
receptor was located on the brush border membrane of the kidney.2 
Transcobalamin (TC, formerly designated as transcobalamin 
II) is a cobalamin (Cbl)-binding polypeptide with a molecular 
weight of 38,000 to 43,000 daltons in humans [1, 2]. Under 
physiological conditions it accounts for at least 80% of the 
approximately 0.75 nmol/liter of the unsaturated Cbl-binding 
capacity of plasma [1], and it facilitates the uptake of Cbl by a 
variety of cells both in vitro [1, 3, 4] and in vivo [5]. 
Low-molecular-weight proteins are generally filtered into the 
primary urine, from which they are efficiently reabsorbed by 
proximal tubule cells. They are then degraded in lysosomes and 
the degradation products return to the circulation [~]. 
Radioactive Cbl, administered either subcutaneously or 
orally to rats, first accumulates mainly in the kidneys and then 
it migrates to other organs [9-11]. Since almost all of the 
administered Cbl binds to TC in blood except when an ex-
tremely large dose is injected, the strong accumulation in the 
kidney suggests a high capacity of this organ to take up 
TC-bound Cbl. Newmark [12] reported that both microbiolog-
ical Cbl activity and intramuscularly injected 57Co-cyanocobal-
amin was concentrated more in the lysosomal fraction of kidney 
than in other subcellular fractions, and speculated that the 
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Cbl-TC complex was reabsorbed and degraded by a similar 
process as low-molecular-weight proteins in general. The cel-
lular uptake of the Cbl-TC complex begins with binding of the 
complex to a specific surface receptor [13, 14]. This report 
describes some characteristics of the Cbl-TC receptor solubi-
lized from hog kidney. 
Methods 
Reagents 
All reagents were commercially available guaranteed-grade 
chemicals. Hog serum albumin (Fraction V, Sigma Chemical 
Co., St. Louis, Missouri, USA) was passed through a Cbl-
Sepharose column before use to remove Cbl binders which 
eluted like TC in gel filtration. 57Co-Cbl with a specific activity 
of 200 Ci/g was from the Radiochemical Centre (England, UK). 
Hog transferrin [15] and hemopexin [16] were purified as 
described before. 
Preparation of receptor extract from kidney with detergent 
Fresh hog kidneys from a slaughterhouse were stored at 
-20°C until used. Receptor extract was prepared from the 
cortex of a kidney by procedures similar to those described for 
preparation of IF-receptor from ileal mucosa [17]. The unsatu-
rated Cbl-binding capacity of the extract was usually less than 
0.4 pmolliiter as determined by the coated charcoal method 
[18]. 
Partial purification of TC from hog serum 
This was performed essentially as described [19]. 
Conversion of holo receptor into apo receptor and partial 
purification of receptor 
A part of the TC receptor in the receptor extract was 
suspected to be saturated with either TC or Cbl-TC (holo 
receptor). To convert the holo receptor into the apo form and to 
remove contaminating proteins, the receptor extract was proc-
essed as follows: Na2-EDTA (Titriplex III, Merck, Germany) 
was added to a kidney extract to a final concentration of 25 
mmolliiter and incubated at room temperature for 30 minutes. 
The mixture was filtered through a Sephadex G-200 column 
equilibrated with EDTA-receptor buffer (vide infra). Fractions 
near the void volume (Vo), which contained Blue Dextran 2,000 
in a concentration more than one-tenth of that in the fraction of 
Yo, were pooled, concentrated by ultrafiltration, dialyzed 
against three changes of extracting buffer for 72 hours and for 48 
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Fig. 1. Assay of TC receptor by gel filtration. Partially purified (pp) 
receptor was incubated with pp TC and 57Co_Cbl for 60 min at room 
temperature. The mixture was filtered through a Sephadex G-200 
column (2.5 x 50 cm) equilibrated with receptor buffer. Fractions of 
3.34 ml were collected and counted for 57CO. Symbols are: (circles) 
complete assay system; (triangles) control system lacking receptor 
preparation; (squares) control system lacking pp TC. 
hours against extracting buffer containing CaCl2 in a concentra-
tion of 10 mmollliter with a change of buffer at 24 hours. In the 
following this preparation is called partially purified (pp) recep-
tor. 
Assay of receptor activity 
Pp TC with a Cbl-binding capacity of 0.25 pmol was incu-
bated with 0.32 pmol of 57Co-Cbl for 30 minutes. The solution 
was mixed with an appropriate volume of pp receptor, brought 
up to 1.0 ml with receptor buffer (vide infra), incubated at room 
temperature for 60 minutes on an end-to-end mixer and then 
filtered through a Sephadex G-200 column. A representative 
elution profile is shoWll in Figure 1. Radioactivity of fractions 
near Vo (hatched area in Fig. 1) was summed up and used as the 
criteria for receptor activity. Controls lacking either the recep-
tor preparation or TC were run separately through the same 
column. 
Gel filtrations 
They were mostly performed in a Sephadex G-2oo column 
(2.5 X 50 cm, 4°C). To investigate the effect of NaCI concen-
tration on the formation of the Cbl-TC-receptor complex, a 
smaller column of 0.9 x 30 cm was used. The flow rates were 
13.3 mllhr for the bigger and 1.9 mllhr for the smaller column. 
Receptor activity assayed on a kidney extract with these two 
columns differed less than 4%. To obtain a saturation curve for 
binding of Cbl-TC to receptor, gel filtrations were made using a 
TSK G 3,OQO SW column. The running buffers for all the three 
columns were 50 mmolliiter Tris-HCI, pH 7.4, containing 0.05% 
Triton X-100, 0.15 mol/liter NaCl, 1.5 mmol/liter NaN3 , and 
either 1 mmol/liter CaCl2 (receptor buffer) or 10 mmol/liter 
Na2-EDTA (EDTA-receptor buffer). 
Protein estimation 
Protein was determined by the original [20] or modified 
Lowry method [21] using bovine serum albumin as a standard. 
In some pp TC preparations also absorbance at 280 nm was 
used. 
Purification of IF and HC 
Hog gastric mucosal scrapings were homogenized. Ammoc 
nium sulfate was added to a concentration of 30% saturation, 
the precipitate was collected by centrifugation and the salt 
concentration was increased to 65% saturation. The resulting 
precipitate containing HC was dissolved and after addition of 
cobinamide it was applied on a Cbl-Sepharose column [22]. The 
breakthrough fraction which contained most of the cobina-
mide-HC complex was dialyzed against 7.5 mol/liter guanidine-
HCI to remove cobinamide and then against phosphate buffer to 
remove guanidine. The dialyzed preparation was applied again 
on Cbl-Sepharose, and after thorough washing HC was eluted 
with guanidine. 
Hog IF was purified from the supernatant of the 65% ammo-
nium sulfate step described above. To the supernatant was 
added cobin amide to block HC and the mixture was applied 
onto a Cbl-Sepharose column. After thorough washing, IF was 
eluted with guanidine, filtered through a TSK G 3,000 SW 
column and fractions corresponding to the elution volume of IF 
were collected. 
Removal of Cbl from holo-TC 
Cbl contained in the pp TC preparation was removed by 
dialyzing the preparation against 10 volumes of 5.0 mol/liter 
guanidine (120 hr) and then against 100 volumes of 50 mmol/liter 
sodium phosphate buffer, pH 6.0, containing 0.2 mol/liter NaCl 
for 120 hours each with four dialysate changes. The Cbl 
concentration in the preparation was estimated with a "Phade-
bas B12 test" (Pharmacia, Uppsala, Sweden). 
Assay of enzyme activities 
Alkaline phosphatase was assayed by a modified method of 
Kind and King [23] using phenyl phosphate as substrate. 
Leucine aminopeptidase was assayed by a modified method of 
Goldbarg and Rutenburg [24] using L-Ieucyl-p-diethyl-amino-
anilide as substrate. y-Glutamyltranspeptidase was assayed by 
a modified method of Orlowski and Meister [25] using y-glu-
tamyl-p-N-ethyl-N-hydroxyethyl aminoanilide as substrate. 
Cytochrome C oxidase was assayed by the method of Wharton 
and Tzagoroff [26]. Glucose-6-phosphatase was assayed by the 
method of Hiibscher and West [27], and J3-g1ucuronidase by the 
method of Plaice [28]. 
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Fig. 2. Injiuence of NaCI concentration on Cbl-TC-receptor complex 
formation. Pp receptor was incubated with pp TC and 57Co-Cbl for 60 
min at room temperature at different concentrations of NaCI. The 
mixtures were filtered through a Sephadex G-200 column equilibrated 
with running buffer containing the same concentration of NaCI as the 
incubation mixture. Symbols are : (solid column) receptor + TC + 
57Co-Cbl ; (hatched column) TC + 57Co-Cbl ; (open column) receptor + 
57Co-Cbl. 
Results 
Assay of receptor for Cb/-TC 
A suitable ionic strength for the gel filtration buffer was found 
to be important because TC aggregated at low ionic strength 
[29, 30] and, on the other hand , high ionic strength inhibited 
protein-protein binding, including binding to the receptor. Ac-
cordingly, we first investigated the effects of N aCI concentra-
tion on the receptor assay. 
At low concentration of NaCI, such as 0.0375 and 0.075 
mol/liter, a large quantity of 57Co-Cbl emerged near the Vo in 
the complete assay system (receptor preparation + pp TC + 
57Co-Cbl). However, most of that radioactivity is probablY due 
to aggregated TC because a control (pp TC + 57Co-Cbl) gave a 
comparable quantity of 57Co-Cbl in the same region. 
In the control system the amount of 57Co-Cbl near Vo 
became insignificant as the concentration of NaCI was in-
creased to 0.15 molfliter (Fig. 2). At NaCl concentrations above 
0.3 molliiter the 57Co-Cbl near the Vo diminished markedly, 
suggesting inhibition of formation of Cbl-TC-receptor complex. 
The recovery of 57Co-Cbl in the effluent was more than 90% 
when the NaCI concentration was above 0.075 mol/liter. 
In the following experiments assay of receptor was per-
formed in a buffer containing 0.t5 molliiter NaCI. The amount 
of Cbl-TC receptor was calculated from the 57Co-Cbl found 
near the Vo in the complete assay system minus the analogous 
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Fig. 3. Rate of formation of Cbl-TC-receptor complex. Pp receptor 
was incubated with pp TC and 57Co-Cbl for a period indicated on the 
abscissa. Formation of Cbl-TC-receptor complex at each incubation 
time was assayed as usual. Mean values and 1 so of 2 to 5 determina-
tions are depicted by closed circles and vertical bars, respectively . 
Figures in parentheses denote number of determinations . *Differences 
of values at 0 and 15 min is statistically insignificant; 0.10 < P < 0.20. 
activity in both control system (pp TC + 57Co-Cbl and receptor 
preparation + 57Co_Cbl). 
Ten mmol/liter Na2-EDTA reduced the formation of the 
Cbl-TC-receptor complex by more than 98%. EDTA treatment 
was used to convert holo to apo receptor as described in 
Methods. The amount of apo receptor in the pp receptor 
preparation so obtained increased, on the average of five 
experiments , by 4.4 times that of original extract. 
Effect of temperature on binding 
Lowering incubation temperature from room temperature 
(22°C) to 4°C decreased binding ofCbl-TC to receptor to 83.6 ± 
7.8% in four experiments. The difference was, however, statis-
tically insignificant. 
Rate of binding 
As shown in Figure 3 binding of Cbl-TC to receptor increased 
to reach a maximum followed by a gradual decrease with 
prolonged incubation time. In some occasions binding at time 0 
was unexpectedly high , although the variation between exper-
iments was quite large. Receptor assay was carried out by gel 
filtration which takes several hours, and reaction of Cbl-TC 
with its receptor is imagined to continue at least for some time 
after the onset of gel filtration. Incubation time indicated on the 
abscissa of Figure 3 is in this sense inevitably inaccurate. 
Saturability of receptor 
Binding of 57Co-Cbl-TC to receptor seemed saturable (Fig. 
4) . By Scatchard analysis the association constant was calcu-
lated to be 4.6 x 109 liter/mol. When a tenfold excess of 
non-radioactive Cbl-TC was added the binding of 57Co-Cbl was 
reduced by 83% (Table 1). This also suggested saturability of 
binding of Cbl-TC to receptor and specificity of the assay 
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Fig. 4. Saturability o/binding o/Cbl-TC to receptor. A fixed amount of 
pp receptor was incubated with 57Co-Cbl-TC at concentration indicated 
on the abscissa and receptor-bound 57Co-Cbl-TC assayed as described 
in the text. Inset: similar data treated according to Scatchard. Inset 
abscissa: concentration of bound ligand (pmollliter). Inset ordinate: 
ratio of concentration of bound ligand to that of free ligand. 
Table 1. Competition for the receptor with Cbl-hog TC by some 
proteins and basic amino compounds 
57Co-Cbl-TC bound 
Molar to receptor 
ratio to % o/control 
57CO_ Number of Extreme 
Test substance Cbl-TC experiments Mean values 
Hog serum albumin 1,000 2 93.8 92.1-95.5 
Hog transferrin 1,300 2 102.2 93.0-11 1.3 
Hog hemopexin 1,000 2 92.9 84.5-101.3 
Ovalbumin 1,000 2 71.9 61.0-81.4 
L-Lysine 100,000 2 121.6 115.5-127.7 
L-Arginine 10,000 2 89.7 86.0-93.3 
6-Amino caproic 100,000 2 112.6 9\.6-133.5 
acid 
Cbl-hog HC 29 2 87.4 85.2-89.6 
Cbl-hog IF 6 1 70.8" 
Partially purified 10 5 33.3 14.7-7\.6 
hogTC 
Partially purified 10 4 17.3 13.7-23.1 
Cbl-hog TC 
a Single experiment due to lack of the material 
system. Addition of similar amounts of pp TC, from which most 
of the endogenous Cbl had been removed as described above 
(apo TC), -in general caused somewhat less reduction of binding 
of 57Co-Cbl to the receptor, with a mean of 67%. However, the 
difference between the effects of holo and apo TC was not 
statistically significant (Table 1). 
Reversibility of binding 
57Co-Cbl-TC-receptor complex was obtained by gel filtration 
similar to assay procedure for the receptor (first gel filtration). It 
was again filtered through a Sephadex G-200 column equili-
Table 2. Reversibility of binding of Cbl-TC to its receptor 
Amount of 57Co_Cbl relative to that of 
Condition of storage of 
Cbl-TC-receptor before 
re-filtration (2nd 
filtration) 
57Co-Cbl-TC-receptor which was applied on 
re-filtration, % 
Cbl-TC-receptor Cbl-TC Free Cbl 
~~~ 
4°C, 0 hr 
4°C, 112 hrs 
2ZOC, 112 hrs 
4°C, 16 hrs, with added 
EDTA 
region 
42" (40,43)b 
32 (30,34) 
27 (32,22) 
0(0,0) 
a Values are means of 2 experiments 
region region 
0(0,0) 2 (0,4) 
0(0,0) 0(0,0) 
0(0,0) 8 (6,10) 
106 (102,110) 19 (20,17) 
b Figures in parentheses are values of each two determinations 
brated with receptor buffer (second gel filtration). About 40% or 
less of the Cbl-TC-receptor was recovered as such (Table 2). 
The low recovery is probably due to absorption of TC or 
receptor moiety of Cbl-TC-receptor complex to gel matrix and 
not to degradation of the complex. This is indicated by the 
absence of any other peaks in the second gel filtration. 
Increasing time and temperature of storage of Cbl-TC-recep-
tor between the first and second gel filtration did not markedly 
reduce the recovery of Cbl-TC-receptor from the second gel 
filtration. Thus binding of Cbl-TC and the receptor seems rather 
stable. 
Subcellular localization of receptors 
The microvillous fraction was prepared from homogenate of 
kidney cortex [31]. Receptor extracts were prepared from both 
whole homogenate and the microvillous fraction. Change of 
specific activity of receptor for TC (Cbl bound via TC/mg 
protein) was compared with some of marker enzymes for 
subcellular organeles. As shown in Table 3, the ratio of specific 
activity of receptor in microvillous fraction to that in whole 
homogenate was roughly same as the corresponding ratio of 
marker enzymes for brush border membranes, that is, alkaline 
phosphatase, leucine aminopeptidase and y-glutamyl-transpep-
tidase. It was quite different from those of cytochrome C 
oxidase, which is a marker for mitochondria, glucose-6-phos-
phatase for microsome and J3-glucuronidase for lysosome frac-
tion. These findings seem to suggest that the receptor is mainly 
localized in the brush border membrane. 
Specificity of binding of Cbl-TC to receptor 
None of the proteins and basic amino compounds that we 
tested clearly interfered with the binding of Cbl-TC to the 
receptor, the only exception being Cbl-HC (Table 1). In prelim-
inary experiments, addition of small amounts of Cbl-hog IF also 
caused a somewhat larger decrease of binding of 57Co-Cbl-TC 
than addition of other proteins. 
Discussion 
The glomerular sieving coefficient for TC and its Cbl complex 
can be estimated to be about 10% based on their molecular 
weight and electric charge. To prevent spillover of significant 
amounts of TC into urine it seems necessary that the tubular 
cells reabsorb it. 
Lindemans, van Kapel and Abels [32] reported on the uptake 
of Cbl-TC by isolated tubular cells of rats. According to the 
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Table 3. Specific activities of receptor for Cbl-TC and marker enzymes in whole homogenate and microvillous fractions from frozen hog 
kidney cortex 
Receptor for TC 
Alkaline phosphatase 
Leucine aminopeptidase 
y-Glutamyltranspeptidase 
Known 
localization 
Brush border 
membrane 
Brush border 
membrane 
Brush border 
Whole 
homogenate 
(H) 
2.22 ± 0.65" 
149 ± 31 b 
184 ± lOe 
0.25 ± 0.04d 
4.52 ± 0.87e 
4.39 ± 0.94f 
Specific activity 
Microvillous 
fraction (MV) 
16.96 ± 5.73" 
825 ± 30b 
1.400 ± 7e 
1.33 ± 0.20d 
0.90 ± ome 
3.87 ± 0.76f 
Relative specific 
activity 
(enrichment) 
MV/H 
7.64 
5.54 
7.61 
5.29 
Cytochrome C oxidase 
Glucose-6-phosphatase 
(3-Glucuronidase 
membrane 
Mitochondrion 
Microsome 
Lysosome 0.203 ± 0.056g 0.202 ± 0.027g 
0.20 
0.88 
0.99 
Values are means ± 1 so of three experiments. 
" fmollmg protein 
b K-A U/mg protein 
e mU/mg protein 
d IU/mg protein 
e k/mg protein 
f f.Lg P/mg protein 
g U/mg protein 
report, the uptake was depressed by metabolic inhibitors, was 
less saturable, decreased dose-dependently by addition of large 
amounts of other proteins and marginally by lysine. With the 
exception of the last item, these characteristics are common 
features in the reabsorption of low-molecular-weight proteins, 
that is, the system is inhibited by basic amino compounds such 
as lysine, arginine, ornithine and 6-amino caproic acid [33], and 
is characterized by low-affinity and low-selectivity [34], but 
high transport capacity [6, 35]. 
However, the present results indicate that the kind of uptake 
of Cbl-TC by the kidney that we studied differs from the usual 
tubular reabsorption of low-molecular-weight proteins. The 
binding of Cbl-TC to the receptor was not inhibited by basic 
amino compounds, it was highly selective and clearly saturable. 
Moreover, in this study the receptor had somewhat higher 
affinity for holo-TC than for apo-TC. Because most of the TC in 
plasma is in the apo-form, it may be taken up by a different 
system such as tubular reabsorption. 
Scott, Bowman and Cookley [36] reported that the binding of 
57Co-Cbl-TC to the plasma membrane of rat kidney was satu-
rable and effectively inhibited by unlabeled Cbl-TC, and some-
what less strongly by apo-TC. This is compatible with our 
findings. Our ~)(udies and those of Scott et al [36] were made on 
the binding of Cbl-TC to a preparation from whole cortex of 
kidney. 
The association constant for the Cbl-TC-receptor system 
agreed closely with those reported for the binding of human 
Cb!-TC to a membrane preparation of placenta [37-39] and of 
rat Cbl-TC to liver plasma membrane [40]. The binding to the 
receptor was inhibited by NaCl in a concentration-dependent 
manner, suggesting that the interaction is more likely ionic than 
hydrophobic. Similar observations were reported by Nex~ and 
Hollenberg [37] on human placenta and rabbit liver. 
Hence, the conclusion seems justified that the kidney con-
tains two systems that bind Cbl-TC. One of them studied by us 
and Scott et al [36] has properties similar to the TC receptors in 
human fibroblast [41], liver [40], placenta [37, 38] and Ehrlich 
as cite cells [3], and is probably necessary for the uptake of such 
Cbl that the organ itself consumes or stores it. The other, 
studied by Lindemans et al [32], is presumably involved in 
tubular reabsorption. 
Thus it seems that the kidneys play a unique role in Cbl 
metabolism in some animal species: They store Cbl when it is 
supplied over body demand and slowly leak it to other organs. 
The kidneys seem to catch and prevent the loss of Cbl by two 
mechanisms, unspecific reabsorption of Cbl-TC and a high 
capacity-specific system for the uptake of Cbl-TC, probablY by 
non-tubular cells. 
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